|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.57(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,971,973 |
52
Week Range: |
$10.31 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,526 |
71,026 |
3,241,429 |
7,930,135 |
Total Sell Value |
$262,322 |
$986,072 |
$41,921,797 |
$106,117,062 |
Total People Sold |
1 |
3 |
4 |
6 |
Total Sell Transactions |
1 |
5 |
18 |
31 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burgess Justin |
Principal Accounting Officer |
|
2022-05-17 |
4 |
S |
$10.00 |
$60,000 |
D/D |
(6,000) |
3,854 |
|
-7% |
|
Burgess Justin |
Principal Accounting Officer |
|
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
9,854 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2022-03-03 |
4 |
S |
$10.56 |
$877,923 |
D/D |
(83,108) |
129,771 |
|
-28% |
|
Janssen Robert |
Senior Vice President |
|
2022-03-03 |
4 |
S |
$10.56 |
$253,998 |
D/D |
(24,036) |
24,707 |
|
-28% |
|
Novack David F |
President & COO |
|
2022-03-03 |
4 |
S |
$10.57 |
$442,481 |
D/D |
(41,862) |
73,213 |
|
-28% |
|
Burgess Justin |
Principal Accounting Officer |
|
2022-03-03 |
4 |
S |
$10.58 |
$227,364 |
D/D |
(21,490) |
3,854 |
|
-28% |
|
Spencer Ryan |
CEO and Director |
|
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,583 |
200,217 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
48,743 |
|
- |
|
Novack David F |
President & COO |
|
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
115,075 |
|
- |
|
Burgess Justin |
Principal Accounting Officer |
|
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,490 |
9,854 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2022-02-15 |
4 |
A |
$10.29 |
$14,993 |
D/D |
1,457 |
162,296 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2022-02-15 |
4 |
A |
$10.29 |
$4,805 |
D/D |
467 |
38,743 |
|
- |
|
Novack David F |
President & COO |
|
2022-02-15 |
4 |
A |
$10.29 |
$10,383 |
D/D |
1,009 |
97,575 |
|
- |
|
Burgess Justin |
Principal Accounting Officer |
|
2022-02-15 |
4 |
A |
$10.29 |
$1,369 |
D/D |
133 |
3,854 |
|
- |
|
Novack David F |
President & COO |
|
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,500 |
96,566 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,000 |
38,276 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
89,250 |
160,839 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2021-11-17 |
4 |
S |
$17.07 |
$912,292 |
D/D |
(53,431) |
8,276 |
|
36% |
|
Janssen Robert |
Senior Vice President |
|
2021-11-17 |
4 |
OE |
$10.47 |
$559,423 |
D/D |
53,431 |
61,707 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2021-11-16 |
4 |
S |
$17.16 |
$617,479 |
D/D |
(35,974) |
8,276 |
|
36% |
|
Janssen Robert |
Senior Vice President |
|
2021-11-16 |
4 |
OE |
$10.47 |
$376,648 |
D/D |
35,974 |
44,250 |
|
- |
|
Novack David F |
President & COO |
|
2021-11-01 |
4 |
AS |
$20.12 |
$402,400 |
D/D |
(20,000) |
44,066 |
|
-49% |
|
Novack David F |
President & COO |
|
2021-10-07 |
4 |
AS |
$18.00 |
$54,000 |
D/D |
(3,000) |
64,066 |
|
-31% |
|
Novack David F |
President & COO |
|
2021-10-01 |
4 |
AS |
$18.23 |
$309,844 |
D/D |
(17,000) |
67,066 |
|
-23% |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-09-01 |
4 |
AS |
$20.00 |
$400,000 |
D/D |
(20,000) |
3,721 |
|
-28% |
|
423 Records found
|
|
Page 5 of 17 |
|
|